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More than 30 years have passed since the first commercial
use of a multi-channel cochlear implant took place, one his-
toric day in Australia. Since then, we have witnessed ever-
improving and truly remarkable cochlear implant outcomes
in adults and children, and the number of Nucleus® implant
recipients has grown to more than 400,000 worldwide.
Cochlear Limited, the company that first brought multi-
channel implants to the market, began with the visionary
work of Professor Graeme Clark and his pioneering team of
multi-disciplinary specialists. For more than three decades,
their spirit of innovation has remained central to Cochlear's
success. One example where this shows is in the development
of smaller, more advanced and easier to use sound processors
e from Cochlear's earliest body-worn processors to the world's
first ear-level processors e and all the way through to the
current Nucleus® 6 processor. Cochlear's ninth generation
sound processor, Nucleus 6, is the smallest and most advanced* Corresponding author.
E-mail address: abeiter@cochlear.com (A.L. Beiter).
Peer review under responsibility of PLA General Hospital Department of
Otolaryngology Head and Neck Surgery.
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gology Head and Neck Surgery. This is an open access article under the CC BY-Non the market. It brings several breakthroughs in hearing
performance, connectivity and lifestyle.
At the most elementary level, all sound processors are
designed to analyze acoustic signals from a microphone(s)
according to specific instructions and algorithms, encode this
information in a form that can be reliably transmitted across
the skin via a radio frequency (RF) carrier to the to the
receiver-stimulator encased in the cochlear implant. The
receiver-stimulator converts transmitted data into bi-phasic
electrical pulses that are sent to the electrodes within the co-
chlea. Cochlear's processors use transcutaneous coupling,
therefore, power for the receiver-stimulator as well as encoded
data are transferred via the RF link.
The earliest processors contained mainly analog with a few
digital circuits and could not process large amounts of data.
Thus, processors such as the Wearable Speech Processor
(WSP) and the Mini Speech Processor (MSP) coded and
delivered basic acoustic parameters such as signal amplitudes,
estimates of the fundamental frequency, first, second formats
and, with the MSP, some higher frequency energy (Clark et al.,
1990; Clark, 2003). Today's processors contain low power,
custom digital signal processing (DSP) chips capable of
quickly executing sophisticated mathematical computations.
These processors implement sophisticated sound processinggapore) Pte Ltd On behalf of PLA General Hospital Department of Otolaryn-
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Interleaved Sampling (CIS), and Advanced Combination
Encoder (ACE) strategies. These encoders present information
at high rates and to more electrodes (channels) within the
cochlea (Clark, 2003; Patrick et al., 2006). Engineers have
invented new DSP algorithms that combine outputs from
multiple microphones to improve listening in difficult listening
environments. Some algorithms specifically remove noisy el-
ements of the acoustic signal. Improvements in signal pro-
cessing have resulted in enhanced outcomes for recipients and
are discussed below (Dawson et al., 2011; Hersbach et al.,
2012; Mauger et al., 2014).
2. Peformance improvements
The advancement of performance outcomes is linked to
both technology improvements and changes in candidacy for
implantable hearing solutions. Because of favorable perfor-
mance outcomes, candidacy has broadened, and because of
broadened candidacy, performance outcomes have further
improved e and the cycle continues. Today many additional
treatment options are available because indications expanded.
These include: middle ear and bone conduction implants,
electro-acoustic implants and direct acoustic cochlear implants
(Fig. 1). Sound processor technologies must also advance to
address these changing candidacy and hearing needs. As an
example, bilateral implantations are more prevalent because of
superior results. There are almost 33,000 bilateral Nucleus
recipients globally and approximately 60% are children and
teens. It is well documented that two ears are better than one
for localization, hearing in noise, sound quality, and ease of
listening (Dunn et al., 2008; Litovsky et al., 2009; Dunn et al.,Fig. 1. Available treatment options related to degree2010a,b; Litovsky, 2011; Ramsden et al., 2012; Galvin et al.,
2013; Hughes and Galvin, 2013; Potts and Litovsky, 2014).
Given the broadened indications, more people with func-
tional residual hearing receive cochlear implants; today there
is an opportunity to use that acoustic hearing when it remains
following surgery. Cochlear™ Hybrid™ Hearing uses acoustic
amplification to improve low-frequency hearing, while the
cochlear implant restores access to high-frequency hearing
that is not available through conventional amplification (Figs.
2 and 3). It is well documented that acoustic hearing provides
important additional information to what recipients receive
electrically (Gantz et al., 2005; Dorman and Gifford, 2010;
Dunn et al., 2010a,b; Gifford et al., 2013; Incerti et al.,
2013; Lenarz et al., 2013; Gifford et al., 2014; Jurawitz
et al., 2014; Roland et al., 2015). Every Nucleus 6 processor
is Hybrid-ready.
As hearing performance improved through fundamental
sound coding advancements, front-end input signal processing
played a larger role in performance increases. Cochlear
introduced SmartSound® processing in 2005 in the Freedom®
sound processor. This processor combined a directional (front)
microphone and an omni-directional (rear) microphone to
create the beamformer. This change allowed for the industry's
first adaptive beamformer to be commercially released
(Patrick et al., 2006; Spriet et al., 2007). SmartSound evolved
further with SmartSound 2; this facilitated different input
processing approaches for a range of listening environments.
There were four pre-defined programs e the Everyday, Noise,
Focus and Music programs, but it required recipients to
manually select and change programs (Wolfe et al., 2012).
Now with the third generation of SmartSound processing in
the Nucleus 6 processor, Cochlear introduces SmartSound®of hearing loss as well as expanded indications.
Fig. 2. Hybrid Hearing uses acoustic amplification to improve low-frequency hearing and electrical stimulation through the cochlear implant to restore high-
frequency hearing.
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classifier (SCAN), the processor automatically and seamlessly
selects the best input signal processing for a listening situation.
SSiQ has two types of programs: first, the default SCAN
program where the classifier analyses the recipient's sound
environment, and automatically selects the appropriate input
processing technologies and microphone directionality for
optimum hearing performance and comfort. Second there are
custom programs where specific technologies can be clinically
specified based on the individual's hearing preferences andFig. 3. The left panel illustrates mean pre-operative aided sound field thresholds a
Cochlear Nucleus Hybrid System FDA clinical trial. The right panel illustrates indlistening requirements (Mauger et al., 2014; Wolfe et al.,
2015).
Mauger et al. (2014) demonstrated the benefit of SCAN's
adaptive directionality in noise; these researchers measured an
average 3.8 dB improvement on an adaptive speech reception
threshold (SRT) test with SCAN compared to no input pro-
cessing or SmartSound 2 (Left graph on Fig. 4). When both
speech and noise came from the front e a very difficult
listening situation e subjects on average performed
1.7e2.3 dB better with SCAN's noise reduction algorithmnd mean Hybrid sound field thresholds at initial activation for subjects in the
ividual subject hearing thresholds in the contralateral ear.
Fig. 4. The left panel illustrates the mean performance improvements with Nucleus 6 using SCAN (SmartSound iQ) in 4 talker babble noise when speech comes
from the front and noise from the sides and behind compared to no SmartSound or SmartSound2. The right panel illustrates the mean performance improvements in
speech weighted noise using the Nucleus 6 signal-to-noise reduction (SNR-NR) algorithm when speech and noise are co-located compared to no SmartSound or
SmartSound2. Also illustrated is the mean performance improvement using Nucleus 6 with SNR-NR compared to performance with subjects' Nucleus 5 processor.
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ing or no input processing at all. Subjects performed on
average 1.7 dB better with Nucleus 6 and SCAN with SNR-
NR compared to their Nucleus 5 (Right graph on Fig. 4).
Recently, audiologists in Cochlear's design and develop-
ment team began fitting Nucleus 6 to some of their first Nu-
cleus 22 recipients. Fig. 5 provides preliminary results
showing good improvements with SCAN, almost a 6 dB
enhancement compared to their Freedom processor in speech
weighted noise and a 5 dB improvement in 4 talker babble
(Cochlear Limited, 2015a,b).
3. Connectivity
Cochlear is the first implant manufacturer to introduce
completely wireless accessories. Previously, the use of audio
accessories with a sound processor required a wired connec-
tion. Although wired accessories work well, many recipients
find them impractical and do not use them as much as they
would like. The convenience of wireless accessories means
more recipients now use audio accessories and enjoy their
benefits. Fig. 6 illustrates the Mini-Microphone, the TV
streamer and the Phone Clip. A recent Mini Microphone study
demonstrated excellent improvement, with an average 8 dB
improvement on recognition of sentences in noise compared to
performance with Nucleus 6 alone (Fig. 7) (Cochlear Limited,
2015a,b).
Nucleus 6 is the industry's first processor with data logging
that monitors and records sound processor and accessory
usage. Clinicians use data logs to visualize device usagepatterns, and gain clinical insights that may help in counseling
the care giver or recipient to achieve a richer hearing journey/
experience.
4. Lifestyle
Implant recipients have benefited from a significant
reduction in sound processor size and improved processor
design. With a 50% reduction in size compared to Freedom®
processors, Nucleus 6 offers a more discreet appearance and
greater comfort. It also carries the Water Resistance rating of
IP57 and water-repellent nano-coating on the processor makes
it more reliable around water than ever before. The Nucleus 6
is compatible with the Cochlear Aqua Accessory, making it
waterproof (IP68), giving recipients the freedom to swim
underwater in a pool, lake or ocean.
5. Future advancements
Cochlear implant technologies will advance with continued
miniaturization of various components, allowing engineers to
design smaller implants and sound processors that also require
less power. Future implants may have different electrode ar-
rays and receiver-stimulators that can be programmed to send
current to the implanted electrodes in novel ways with the
potential to focus electrical stimulation and potentially in-
crease the number of independent channels, thus improving
recipients' speech understanding (Bierer, 2010; Long et al,
2014). New electrode array designs will further minimize
cochlear trauma and could deliver various therapeutic drugs to
Fig. 5. The left panel illustrates mean performance improvements in speech weight noise for Nucleus 22 subjects using the default SCAN program compared to
their Freedom processor and to Nucleus 6 using a program without SCAN. The right panel illustrates mean performance improvements in 4 talker babble noise for
Nucleus 22 subjects using the default SCAN program compared to their Freedom processor and to Nucleus 6 using a program without SCAN.
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(Wilson and Dorman, 2008; Jolly et al., 2010; Shepherd, 2011;
Astolfi et al., 2014).
Another exciting development is the research totally
implantable cochlear implant (TIKI) developed by Cochlear
Limited and the Co-operative Research Centre for Cochlear
Implant and Hearing Aid Innovation (Briggs et al., 2008;Fig. 6. Cochlear's wireless accessories: Mini MBriggs, 2011). Three adults with severe to profound sensori-
neural hearing loss were implanted expressly for research
purposes with the TIKI at the University of Melbourne
Cochlear Implant Clinic, without any surgical or postoperative
complications. These three subjects are able to use their TIKI
in both “invisible hearing” mode or with their external ESPrit
3G sound processor. The major limitation of this researchicrophone, TV Streamer and Phone Clip.
Fig. 7. Mean performance on the Bamford Kowal Bench speech reception threshold test (SRT) in noise using the Nucleus 6 alone and the Nucleus 6 with the Mini
Microphone.
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tivity such that speech intelligibility is somewhat degraded
with invisible hearing mode compared to outcomes with the
ESPrit 3G processor. Additionally, body noise interference is
bothersome and reduces the amount of time subjects use their
invisible hearing. Research is ongoing to improve the subcu-
taneous microphone and signal processing.
6. Conclusion
Over the last 30 plus years, Cochlear has consistently
produced many sound processor innovations. At the same
time, speech perception outcomes have greatly improved
leading to expanded indications, with more and more in-
dividuals accessing the range of our technologies. Lifestyle
considerations and connectivity demands are becoming as
important as hearing performance in propelling the design of
sound processors. Cochlear remains firmly committed to
backwards compatibility delivering on the promise of “Hear
Now and Always” to our earliest cochlear implant recipients.
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